CD73

CD73

CD73 Overview

Molecule Name
5'-nucleotidase
Synonyms
CD73,NT5E,5'-Nucleotidase,5'-NT,NT5,NTE
Drug Development Progress
Drugs in Clinical Trials36
Approved Drugs0
Highest Development StagePhase 3 Clinical
Target Synonym
5' Nucleotidase (CD73),5'-nucleotidase,5'-Nucleotidase, Ecto (CD73),Ecto-5'-nucleotidase,NT5E,5'-Nucleotidase Ecto,Ecto-5-Nucleotidase,5-NT,Purine 5-Prime-Nucleotidase,5-Nucleotidase, Ecto (CD73),5 Nucleotidase (CD73),5-Nucleotidase Ecto,5-Nucleotidase,CD73 Antigen,EC 3.1.3.5,CALJA,E5NT,ENT,NT,EN,CD73,5'-NT,NT5,NTE,EC:3.1.3.5
Background
5'-nucleotidase (5'-NT), also known as ecto-5'-nucleotidase or CD73 (cluster of differentiation 73), is an enzyme that is encoded by the NT5E gene. CD73 commonly serves to convert AMP to adenosine. Ecto-5-prime-nucleotidase (5-prime-ribonucleotide phosphohydrolase) catalyzes the conversion at neutral pH of purine 5-prime mononucleotides to nucleosides, the preferred substrate being AMP. Other forms of 5-prime nucleotidase exist in the cytoplasm and lysosomes and can be distinguished from ecto-NT5 by their substrate affinities, requirement for divalent magnesium ion, activation by ATP, and inhibition by inorganic phosphate. Rare allelic variants are associated with a syndrome of adult-onset calcification of joints and arteries (CALJA) affecting the iliac, femoral, and tibial arteries reducing circulation in the legs and the joints of the hands and feet causing pain.

CD73 Product List

Species
  • Human(3)
  • Canine(1)
  • Cynomolgus(1)
  • Mouse(1)
  • Rabbit(1)
  • Rat(1)
Tag
  • His Tag(6)
  • His Tag & Avi Tag(1)
  • Mouse IgG Fc Tag(1)
Host
  • HEK293(8)
Conjugate
  • Unconjugated(7)
  • Biotin-labeled(1)
Grade
  • RUO(8)
Low Endotoxin
  • No(8)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
CD73
Mouse CD73 / NT5E Protein, His Tag (active enzyme)
Mouse
HEK293
SDS-PAGE
Enzyme

$125.00

20ug
CD73
HOTAvitag
CD3-H82E3
Biotinylated Human CD73 / NT5E Protein, His,Avitag™
Human
HEK293
SDS-PAGE
ELISASPR

$360.00

25ug
CD73
Human CD73 / NT5E Protein, His Tag (HPLC verified) (active enzyme)
Human
HEK293
HPLCSDS-PAGE
ELISASPRBLIEnzyme

$145.00

20ug
CD73
Canine CD73 / NT5E Protein, His Tag (MALS verified) (active enzyme)
Canine
HEK293
MALSSDS-PAGE
Enzyme

$360.00

100ug
CD73
Cynomolgus CD73 Protein, His Tag (active enzyme)
Cynomolgus
HEK293
SDS-PAGE
ELISASPREnzyme

$360.00

100ug
CD73
Human CD73 Protein, Mouse IgG2a Fc Tag (active enzyme)
Human
HEK293
SDS-PAGE
ELISAEnzyme

$360.00

100ug
CD73
Rabbit CD73 / NT5E Protein, His Tag (active enzyme)
Rabbit
HEK293
SDS-PAGE
Enzyme

$360.00

100ug
CD73
Rat CD73 Protein, His Tag (active enzyme)
Rat
HEK293
SDS-PAGE
Enzyme

$125.00

20ug
You Have Viewed 1-8 Of 8 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
UliledlimabTJD-5; TJ-004309; TJ-4309Phase 3 ClinicalI-Mab Biopharma Co Ltd
Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Neoplasm Metastasis; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
Details
QuemliclustatAB-680Phase 3 ClinicalArcus Biosciences Inc
Adenocarcinoma; Bile Duct Neoplasms; Biliary Tract Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colorectal Neoplasms; Hormone-Resistant Prostate Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Details
OleclumabMEDI-9447Phase 3 ClinicalMedimmune Llc
Adenocarcinoma; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Colorectal Neoplasms; Fallopian Tube Neoplasms; Hemangiosarcoma; Liposarcoma; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms
Details
Dalutrafusp alfaGS-1423; AGEN-1423Phase 2 ClinicalAgenus Inc
Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
BMS-986179BMS-986179Phase 2 ClinicalBristol-Myers Squibb Company
Solid tumours
Details
MupadolimabCPX-006; COR-004 (Corvus Pharmaceuticals); CPI-006Phase 2 ClinicalCorvus Pharmaceuticals Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Endometrial Neoplasms; Head and Neck Neoplasms; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Pancreatic Neoplasms; Papillomavirus Infections; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms
Details
XW-LTH-03XW-LTH-03Phase 2 ClinicalShanghai SinoBay Biotechnology Co Ltd
Stomach Neoplasms
Details
CD73/AXL.HypoSti.CAR-T cells therapy (Pla General Hospital)Phase 2 ClinicalPla General Hospital
Solid tumours
Details
DresbuxelimabAK-119Phase 2 Clinical
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis; Solid tumours
Details
GI-108GI-108Phase 2 ClinicalGI Innovation Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Neoplasms; Pancreatic Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
Details
S-095024S-095024; S095024Phase 2 ClinicalInstitut De Recherches Internationales Servier, Regeneron Pharmaceuticals Inc, Servier Bio-Innovation LLC
Carcinoma, Non-Small-Cell Lung
Details
HB-0052HB0052; HB-0052Phase 2 ClinicalShanghai Huaota Biopharmaceutical Co Ltd, Zhejiang Huahai Pharmaceutical Co Ltd
Pancreatic Neoplasms; Solid tumours
Details
HB-0045HB-0045; HB0045Phase 2 ClinicalHuaBo Biopharm Co Ltd, Shanghai Huaota Biopharmaceutical Co Ltd
Solid tumours
Details
JAB-BX102JAB-BX102Phase 2 ClinicalJacobio Pharmaceuticals Co Ltd
Solid tumours
Details
PT-199PT-199Phase 2 ClinicalPhanes Therapeutics Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Solid tumours
Details
LY-3475070LY-3475070Phase 1 ClinicalEli Lilly And Company
Neoplasms
Details
Anti-CD73 monoclonal antibody (Bristol-Myers Squibb)Phase 1 ClinicalBristol-Myers Squibb Company
Neoplasms
Details
AP-601AP-601Phase 1 ClinicalAP Biosciences Inc
Neoplasms; Solid tumours
Details
68Ga-dPNE68Ga-dPNEPhase 1 ClinicalFirst Affiliated Hospital Of Fujian Medical University
Neoplasms
Details
AK-137AK137; AK-137Phase 1 Clinical
Neoplasms
Details
68GA-DOTA-dPNE68GA-DOTA-dPNEPhase 1 ClinicalPeking Union Medical College Hospital
Breast Neoplasms
Details
LNF-2008LNF-2008; LNF2008Phase 1 ClinicalShandong New Time Pharmaceutical Co Ltd
Solid tumours
Details
HB-0046HB0046; HB-0046Phase 1 ClinicalHuaBo Biopharm Co Ltd, Shanghai Huaota Biopharmaceutical Co Ltd
Solid tumours
Details
SYS-6011SYS6011; SYS-6011Phase 1 ClinicalJushi Biopharmaceutical Co Ltd
Solid tumours
Details
BPI-472372BPI-472372Phase 1 ClinicalBetta Pharmaceuticals Co Ltd
Solid tumours
Details
BB-1709BB-1709Phase 1 ClinicalBliss Biopharmaceutical (Hangzhou) Co Ltd
Solid tumours
Details
PM-1015PM1015; PM-1015Phase 1 Clinical
Solid tumours
Details
AK-131AK-131Phase 1 Clinical
Neoplasms; Solid tumours
Details
IBI-325IBI-325Phase 1 Clinical
Solid tumours
Details
BR-101BR101; BR-101Phase 1 ClinicalZhejiang BioRay Biopharmaceuticals Co Ltd
Solid tumours
Details
CB-708ATG-037; ATN-037; CB-708; CB708Phase 1 ClinicalCalithera Biosciences Inc
Carcinoma, Non-Small-Cell Lung; Melanoma; Neoplasms; Solid tumours
Details
HLX-23HLX-23Phase 1 Clinical
Lymphoma; Solid tumours
Details
ORIC533ORIC-533Phase 1 ClinicalOric Pharmaceuticals Inc
Multiple Myeloma; Neoplasm Metastasis
Details
IPH-5301IPH-5301Phase 1 ClinicalInnate Pharma
Breast Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Lung Neoplasms; Metastatic breast cancer; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
HBM-1007HBM1007; R 1007; HBM 1007; HBM-1007Phase 1 ClinicalHarbour Biomed
Neoplasms; Solid tumours
Details
ABSK-051ABSK051Phase 1 ClinicalABbisko Therapeutics Co Ltd
Neoplasms; Solid tumours
Details
Customer Reviews
  • H***g2021-11-29
    It was used in research of investgational new drugs. Specifically, I have used this product in my Epitope binning experiments (using Octet) and I am truely satisfied with the results. With this experiment and your product, we have found a approximate epitope binding site. Thanks for your highly qualified product.